0 Commentarii
0 Distribuiri
1029 Views
0 previzualizare
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
- Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
- Europe and U.S. Lead Global Expansion in Plasmid DNA Manufacturing MarketThe global plasmid DNA manufacturing market, valued at USD 2.38 billion in 2024, is anticipated to expand at a CAGR of 21.7% from 2025 to 2034, with growth increasingly driven by segment-wise performance across scale, end-user applications, and technological platforms. Unlike traditional plasmid production for research, GMP-compliant manufacturing for clinical and commercial use requires...0 Commentarii 0 Distribuiri 1065 Views 0 previzualizare
- Plasmid DNA Manufacturing Market Segmentation Analysis by Application, End-Use, and RegionThe global plasmid DNA manufacturing market, valued at USD 2.38 billion in 2024, is anticipated to register a compound annual growth rate (CAGR) of 21.7% from 2025 to 2034, driven by the explosive demand for high-purity plasmid DNA (pDNA) as a foundational component in gene therapies, mRNA vaccines, and viral vector production. As the biopharmaceutical industry shifts toward advanced modalities...0 Commentarii 0 Distribuiri 980 Views 0 previzualizare
- Powering Gene Therapy: Growth in the Viral Vector and Plasmid DNA Manufacturing Market“According to a new report published by Introspective Market Research, titled, Viral Vector and Plasmid DNA Manufacturing Market by Vector Type, Workflow, Application, and End-User, The Global Viral Vector and Plasmid DNA Manufacturing Market Size Was Valued at USD 5.4 Billion in 2023 and is Projected to Reach USD 28.9 Billion by 2032, Growing at a CAGR of 20.9%.” Introduction /...0 Commentarii 0 Distribuiri 508 Views 0 previzualizare
- Segment-Wise Pricing, Performance, and Adoption Trends in the Global Plasmid DNA Manufacturing MarketThe global plasmid DNA manufacturing market, valued at USD 2.38 billion in 2024, is anticipated to expand at a CAGR of 21.7% from 2025 to 2034, with growth increasingly driven by segment-wise performance across scale, end-user applications, and technological platforms. Unlike traditional plasmid production for research, GMP-compliant manufacturing for clinical and commercial use requires...0 Commentarii 0 Distribuiri 997 Views 0 previzualizare
© 2026 La Lingua Nostra
Romaian